
Pharmaceutical major Amgen Inc. (AMGN) is scheduled to report its third-quarter earnings on October 31. In this piece, I have discussed why it could be wise to buy the stock now.
Wall Street expects a year-over-year decline in earnings on higher revenues when AMGN reports results for the quarter ended September 30, 2023. While the company’s revenue is expected to increase 4.5% year-over-year to $6.95 billion, its EPS is expected to decline 0.4% to $4.68.